Recently, Philip Brooks sent me a note from one of the readers of his excellent Patent Infringement Updates site. The note was regarding the generic challenge where a brand-name drug has recently gone generic and the drug manufacturer wishes to launch the product in a new indication. The reader asked if the manufacturer would be […]

There are a lot of blogs in the world so I tend to cringe when I see another one (I don’t want to have to keep up with yet more information). But, I’ll just mention a new collaborative law blog, named Blawgr, that was set loose last month as the brainchild of Stephen Nipper, Doug […]

Matt Buchanan, at Promote the Progress, has written about an op-ed piece in today’s edition of the Wall Street Journal. You can view the article here (subscription required). The piece is labeled with the very unoriginal title “Patently Absurd” – just like a lot of other tired articles – and appears to be another in […]